ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Association of Trugraf GEP with Clinical and Histological Outcomes in a Multicenter Cohort (TOGETHER Study)

    R. Heilman1, W. Park2, M. Mai3, B. Smith2, R. First4, J. Fleming4, P. West-Thielke4, J. Holman4, M. Stegall2

    1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Jacksonville, FL, 4Transplant Genomics, Framingham, MA

    *Purpose: The purpose of this study was to validate the association of TruGraf GEP with clinical endpoints in a real-world cohort.*Methods: This was a multicenter…
  • 2022 American Transplant Congress

    Use of Organ-Specific Chimeric Antigen Receptor Promotes Liver Recruitment of Regulatory T Cells

    E. Landmann1, P. Ruiz1, A. Kurt1, E. Kodela1, M. Martinez-Llordella2, A. Sanchez-Fueyo1

    1King's College London, London, United Kingdom, 2Quell Therapeutics, London, United Kingdom

    *Purpose: Owing to their potent immune-modulatory properties, regulatory T cells (Tregs) have been explored as novel cell therapy to induce allograft tolerance, with first clinical…
  • 2022 American Transplant Congress

    Modern Medicine Needs Modern Technology Tools

    Z. S. Soltani,, S. Soltani

    Ochsner Foundation Hospital, New Orleans, LA

    *Purpose: Dd-cfDNA has been used as a non-invasive biomarker for allograft injury and has been shown to detect subclinical rejection with higher predictive power compare…
  • 2022 American Transplant Congress

    Older Donor Age is Associated with Worse Living Donor Liver Transplantation Outcomes in a National US Cohort

    M. Kanneganti1, K. M. Olthoff2, T. Bittermann3

    1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 2Department of Surgery, University of Pennsylvania, Philadelphia, PA, 3Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA

    *Purpose: To evaluate the impact of increasing living donor (LD) age on living donor liver transplantation (LDLT) outcomes in the U.S.*Methods: A retrospective cohort of…
  • 2022 American Transplant Congress

    A Qualitative Comparison of Declined Hispanic and Non-Hispanic Living Liver Donor Candidates at a High-Volume Urban Transplant Center

    D. Toy1, B. Horwich1, A. Mulgaonkar1, A. Padilla2, J. L. Dodge3, N. Kaur4, H. Han3

    1Department of Medicine, University of Southern California, Los Angeles, CA, 2USC Transplant Institute, University of Southern California, Los Angeles, CA, 3Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, CA, 4Department of Surgery, University of Southern California, Los Angeles, CA

    *Purpose: To compare Hispanic and non-Hispanic living liver donor candidates who were declined by a multidisciplinary selection committee at a large urban transplant center.*Methods: The…
  • 2022 American Transplant Congress

    Is Remnant Liver Volume Ratio Less Than 30% Still Contraindication to Right Hepatectomy for Living Liver Donors?

    J. Kim, D. Choi

    Department of Surgery, Catholic University of Daegu College of Medicine, Daegu, Korea, Republic of

    *Purpose: Recently, some centers reported that extended resection with remnant/total volume ratio(RTVR) less than 30% for living donor right hepatectomy(LDRH) but there is no consensus…
  • 2022 American Transplant Congress

    Duration of Brain Death Does Not Impact Short Term Outcomes in Kidney Transplantation

    A. M. Hawxby1, R. Ketcham2, J. P. Orlowski3, R. A. Squires2, C. Hostetler2

    1Organ Recovery, LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK, 2LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK, 3LifeShare Transplant Donors Services, Oklahoma City, OK

    *Purpose: In animal models, brain death has been shown to induce renal injury, primarily due to ischemia, inflammation, and alterations in hemodynamics. However, donor management…
  • 2022 American Transplant Congress

    Distinct Phenotypes of Kidney Transplant Recipients Aged 80 Years or Older in the United States by Machine Learning Consensus Clustering

    S. A. Mao1, C. Thongprayoon2, M. A. Mao3, C. C. Jadlowiec4, N. Leeaphorn5, M. Cooper6, W. Cheungpasitporn2

    1Transplant Surgery, Mayo Clinic, Jacksonville, FL, 2Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 3Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL, 4Transplant Surgery, Mayo Clinic, Phoenix, AZ, 5Renal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO, 6MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC

    *Purpose: Our study aimed to cluster very elderly kidney transplant recipients aged 80 years and above using an unsupervised machine learning approach.*Methods: We performed consensus…
  • 2022 American Transplant Congress

    Cardiomyocyte Cross-Sectional Area Increases After Orthotopic Cardiac Xenotransplantation and is Not Likely a Significant Contributor to Xenograft Growth up to 9 Months

    C. E. Goerlich1, B. Griffith1, J. Treffalls1, P. Hanna2, S. N. Hong2, A. K. Singh1, D. Ayares3, M. Mohiuddin1

    1Surgery, University of Maryland School of Medicine, Baltimore, MD, 2Department of Medicine, Division of Cardiology, University of Maryland School of Medicine, Baltimore, MD, 3Revivicor, Inc., Blacksburg, VA

    *Purpose: Genetically engineered (GE) pigs are thought to be an alternative organ source for patients in end-stage heart failure unable to receive a timely allograft.…
  • 2022 American Transplant Congress

    Pre-Transplant Self-Report of Length of Sobriety is Not Significantly Related to Early Return to Alcohol Use Post Transplant

    J. Esswein1, A. Powell1, H. Bruschwein2, S. Weinland1

    1Psychiatry, VCU School of Medicine, Richmond, VA, 2The University of Virginia, Charlottesville, VA

    *Purpose: Many transplant centers in the United States require six months of abstinence from alcohol prior to liver transplant. Recently, there has been an increased…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences